This trial will investigate if Urolithin A can help prevent muscle decline during illness or injury when people can't use their muscles.
- Healthy Subjects
- Muscle Atrophy
1 Primary · 3 Secondary · Reporting Duration: Day 7, Day 14, Day 28, Day 35; integrated synthesis rates reported for Day 7-14, Day 14-28; Day 28-35
Awards & Highlights
2 Treatment Groups
1 of 2
Protein supplement with Urolithin A
1 of 2
24 Total Participants · 2 Treatment Groups
Primary Treatment: Protein supplement with Urolithin A · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 30 · Male Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does the research team have any age restrictions for participants?
"This medical trial has set a requirement that all participants must be older than 18 and younger than 30 in order to meet the inclusion criteria." - Anonymous Online Contributor
Are new participants being accepted for this research initiative?
"Correct. Data hosted on clinicaltrials.gov reveals that this medical investigation, which was initially uploaded to the site in June 1st 2023, is presently accepting participants. 24 individuals need to be sourced from a single research centre." - Anonymous Online Contributor
To what extent are participants engaged in this clinical trial?
"Affirmative. The clinical trial is actively recruiting participants, as displayed on the data hosted at clinicaltrials.gov which was last modified on April 14th 2023. This study requires 24 people to be enrolled from a single site." - Anonymous Online Contributor
Who qualifies to partake in this experimental research?
"To qualify for the study, individuals must be within 18 to 30 years of age and have no major health issues. A total of 24 participants are being recruited." - Anonymous Online Contributor